Department of Pharmaceutical Sciences, University of Catania, 95125 Catania, Italy
I.N.M. Neuromed, Localita Camerelle, 86077, Pozzilli, Italy
IRCCS Associazione Oasi Maria S.S., Institute for Research on Mental Retardation and Brain Aging, 94018 Troina, Enna, Italy
Department of Experimental and Clinical Pharmacology, University of Catania, 95125 Catania, Italy
Department of Human Physiology and Pharmacology, University of Rome La Sapienza, 00185 Rome, Italy
I.B.B., CNR-Catania, 95125 Catania, Italy
I. N. M. Neuromed, Localita Camerelle, 86077, Pozzilli, Italy
I. B. B., CNR-Catania, 95125 Catania, Italy
References: Brazil, D.P., Hemmings, B.A., Ten years of protein kinase B signalling: a hard Akt to follow (2001) Trends Biochem. Sci., 26, pp. 657-66
Brinton, R.D., Impact of estrogen therapy on Alzheimer's disease: a fork in the road? (2004) CNS Drugs, 18, pp. 405-422
Brionne, T.C., Tesseur, I., Masliah, E., Wyss Coray, T., Loss of TGF-β1 leads to increased neuronal cell death and microgliosis in mouse brain (2003) Neuron, 40, pp. 1133-1145
Bruno, V., Battaglia, G., Casabona, G., Copani, A., Caciagli, F., Nicoletti, F., Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta (1998) J. Neurosci., 18, pp. 9594-9600
Butterfield, D.A., Reed, T., Newman, S.F., Sultana, R., Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment (2007) Free Radic. Biol. Med., 43, pp. 658-677
Caricasole, A., Copani, A., Caraci, F., Aronica, E., Rozemuller, A.J., Caruso, A., Storto, M., Nicoletti, F., Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain (2004) J. Neurosci., 24, pp. 6021-6027
Castren, E., Tanila, H., Neurotrophins and dementia-keeping in touch (2006) Neuron, 51, pp. 1-3
Chalmers, K.A., Love, S., Neurofibrillary tangles may interfere with Smad 2/3 signaling in neurons (2007) J. Neuropathol. Exp. Neurol., 66, pp. 158-167
Connor, B., Dragunow, M., The role of neuronal growth factors in neurodegenerative disorders of the human brain (1998) Brain Res. Brain Res. Rev., 27, pp. 1-39
Copani, A., Bruno, V., Battaglia, G., Lenza, G., Pellitteri, R., Russo, A., Stanzani, S., Nicoletti, F., Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide (1995) Mol. Pharmacol., 47, pp. 890-897
Copani, A., Condorelli, F., Caruso, A., Vancheri, C., Sala, A., Giuffrida Stella, A.M., Canonico, P.L., Sortino, M.A., Mitotic signaling by beta-amyloid causes neuronal death (1999) FASEB J., 13, pp. 2225-2234
Copani, A., Sortino, M.A., Caricasole, A., Chiechio, S., Chisari, M., Battaglia, G., Giuffrida-Stella, A.M., Nicoletti, F., Erratic expression of DNA polymerases by beta-amyloid causes neuronal death (2002) FASEB J., 16, pp. 2006-2008
Copani, A., Hoozemans, J.J., Caraci, F., Calafiore, M., Van Haaster, E.S., Veerhius, R., Rozemuller, A.J.M., Nicoletti, F., DNA polymerase-β is early expressed in neurons of Alzheimer's Disease brain and is loaded into DNA replication forks in neurons challenged with β-amyloid (2006) J. Neurosci., 26, pp. 10949-10957
Demuro, A., Mina, E., Kayed, R., Milton, S.C., Parker, I., Glabe, C.G., Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers (2005) J. Biol. Chem., 280, pp. 17294-17300
Derynck, R., Zhang, Y.E., Smad-dependent and Smad-independent pathways in TGF-beta family signalling (2003) Nature, 425, pp. 577-584
Fuentealba, R.A., Farias, G., Scheu, J., Bronfman, M., Marzolo, M.P., Inestrosa, N.C., Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease (2004) Brain Res. Brain Res. Rev., 47, pp. 275-289
Gaertner, R.F., Wyss-Coray, T., Von Euw, D., Lesne, S., Vivien, D., Lacombe, P., Reduced brain tissue perfusion in TGF-beta 1 transgenic mice showing Alzheimer's disease-like cerebrovascular abnormalities (2005) Neurobiol. Dis., 19, pp. 38-46
Garcia, Z., Kumar, A., Marques, M., Cortes, I., Carrera, A.C., Phosphoinositide 3-kinase controls early and late events in mammalian cell division (2006) EMBO J., 25, pp. 655-661
Giovanni, A., Wirtz-Brugger, F., Keramaris, E., Slack, R., Park, D.S., Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F-DP, in β-amyloid-induced neuronal death (1999) J. Biol. Chem., 274, pp. 19011-19016
Giuffrida, M.L., Grasso, G., Ruvo, M., Pedone, C., Saporito, A., Marasco, D., Pignataro, B., Rizzarelli, E., Abeta(25-35) and its C- and/or N-blocked derivatives: copper driven structural features and neurotoxicity (2007) J. Neurosc. Res., 85, pp. 623-633
Grammas, P., Ovase, R., Cerebrovascular transforming growth factor-β contributes to inflammation in the Alzheimer's disease brain (2002) Am. J. Pathol., 160, pp. 1583-1587
Hardy, J., Selkoe, D.J., The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics (2002) Science, 297, pp. 353-356
Harris-White, M.E., Chu, T., Balverde, Z., Sigel, J.J., Flanders, K.C., Frautschy, S.A., Effects of transforming growth factor-beta (isoforms 1-3) on amyloid-beta deposition, inflammation, and cell targeting in organotypic hippocampal slice cultures (1998) J. Neurosci., 18, pp. 10366-10374
Herrup, K., Neve, R., Ackerman, S.L., Copani, A., Divide and die: cell cycle events as triggers of nerve cell death (2004) J. Neurosci., 24, pp. 9232-9239
Hock Jr., B.J., Lamb, B.T., Transgenic mouse models of Alzheimer's disease (2001) Trends Genet., 17, pp. S7-S12
Hynd, M.R., Scott, H.L., Dodd, P.R., Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease (2004) Neurochem. Int., 45, pp. 583-595
Inman, G.J., Nicolas, F.J., Callahan, J.F., Harling, J.D., Gaster, L.M., Reith, A.D., Laping, N.J., Hill, C.S., SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7 (2002) Mol. Pharmacol., 62, pp. 65-74
Kihara, T., Shimohama, S., Sawada, H., Honda, K., Nakamizo, T., Shibasaki, H., Kume, T., Akaike, A., alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity (2001) J. Biol. Chem., 276, pp. 13541-13546
Kim, E.S., Kim, R.S., Ren, R.F., Hawver, D.B., Flanders, K.C., Transforming growth factor-beta inhibits apoptosis induced by beta-amyloid peptide fragment 25-35 in cultured neuronal cells (1998) Brain Res. Mol. Brain Res., 62, pp. 122-130
Lai, Y.L., Smith, P.M., Lamm, W.J.E., Hildebrandt, J., Sampling and analysis of cerebrospinal fluid for chronic studies in awake rats (1983) J. Appl. Physiol., 54, pp. 1754-1757
Lee, H.G., Ueda, M., Zhu, X., Perry, G., Smith, M.A., Ectopic expression of phospho-Smad2 in Alzheimer's disease: uncoupling of the transforming growth factor-beta pathway? (2006) J. Neurosci. Res., 84, pp. 1856-1861
Luterman, J.D., Haroutunian, V., Yemul, S., Ho, L., Purohit, D., Aisen, P.S., Mohs, R., Pasinetti, G.M., Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia (2000) Arch. Neurol., 57, pp. 1153-1160
Makwana, M., Jones, L.L., Cuthill, D., Heike Heuer, H., Bohatschek, M., Hristova, M., Friedrichsen, S., Raivich, G., Endogenous transforming growth factor β1 suppresses inflammation and promotes survival in adult CNS (2007) J. Neurosci., 27, pp. 11201-11213
Mattson, M.P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., Rydel, R.E., beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity (1992) J. Neurosci., 12, pp. 376-389
Miguel-Hidalgo, J.J., Cacabelos, R., Beta-amyloid(1-40)-induced neurodegeneration in the rat hippocampal neurons of the CA1 subfield (1998) Acta Neuropathol. (Berl), 95, pp. 455-465
Morimoto, K., Yoshimi, K., Tonohiro, T., Yamada, N., Oda, T., Kaneko, I., Co-injection of beta-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons (1998) Neuroscience, 84, pp. 479-487
Murase, S., Mosser, E., Schuman, E.M., Depolarization drives beta-catenin into neuronal spines promoting changes in synaptic structure and function (2002) Neuron., 35, pp. 91-105
Pike, C.J., Burdick, D., Walencewicz, A.J., Glabe, C.G., Cotman, C.W., Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state (1993) J. Neurosci., 13, pp. 1676-1687
Prehn, J.H., Bindokas, V.P., Jordan, J., Galindo, M.F., Ghadge, G.D., Roos, R.P., Boise, L.H., Miller, R.J., Protective effect of transforming growth factor-beta 1 on beta-amyloid neurotoxicity in rat hippocampal neurons (1996) Mol. Pharmacol., 49, pp. 319-328
Ren, R.F., Flanders, K.C., Transforming growth factors-beta protect primary rat hippocampal neuronal cultures from degeneration induced by beta-amyloid peptide (1996) Brain Res., 732, pp. 16-24
Rossig, L., Badorff, C., Holzmann, Y., Zeiher, A.M., Dimmeler, S., Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21 Cip1 degradation (2002) J. Biol. Chem., 277, pp. 9684-9689
Shapiro, G.I., Preclinical and clinical development of the cyclin-dependent kinase inhibitor flavopiridol (2004) Clin. Cancer Res., 10, pp. 4270-4275
Shaw, M., Cohen, P., Alessi, D.R., Further evidence that the inhibition of glycogen synthase kinase-3beta by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9 and not by dephosphorylation of Tyr-216 (1997) FEBS Lett., 416, pp. 307-311
Sortino, M.A., Chisari, M., Merlo, S., Vancheri, C., Caruso, M., Nicoletti, F., Canonico, P.L., Copani, A., Glia mediates the neuroprotective action of estradiol on beta-amyloid-induced neuronal death (2004) Endocrinology, 145, pp. 5080-5086
Swanson, C.J., Bures, M., Johnson, M.P., Linden, A.M., Monn, J.A., Schoepp, D.D., Metabotropic glutamate receptors as novel targets for anxiety and stress disorders (2005) Nat. Rev., Drug Discov., 4, pp. 131-144
Takashima, A., Honda, T., Yasutake, K., Michel, G., Murayama, O., Murayama, M., Ishiguro, K., Yamaguchi, H., Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons (1998) Neurosci Res., 31, pp. 317-323
Takashima, A., Murayama, M., Murayama, O., Kohno, T., Honda, T., Yasutake, K., Nihonmatsu, N., Wolozin, B., Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau (1998) Proc. Natl. Acad. Sci. U. S. A., 95, pp. 9637-9641
Ten Dijke, P., Hill, C.S., New insights into TGF-beta-Smad signalling (2004) Trends Biochem. Sci., 29, pp. 265-273
Tesseur, I., Zou, K., Esposito, L., Bard, F., Berber, E., Can, J.V., Lin, A.H., Wyss-Coray, T., Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology (2006) J. Clin. Invest., 116, pp. 3060-3069
Ueberham, U., Ueberham, E., Gruschka, H., Arendt, T., Altered subcellular location of phosphorylated Smads in Alzheimer's disease (2006) Eur. J. Neurosci., 24, pp. 2327-2334
Wyss-Coray, T., Tgf-Beta pathway as a potential target in neurodegeneration and Alzheimer's (2006) Curr. Alzheimer Res., 3, pp. 191-195
Wyss-Coray, T., Masliah, E., Mallory, M., McConlogue, L., Johnson-Wood, K., Lin, C., Mucke, L., Amyloidogenic role of cytokine TGF-β1 in transgenic mice and Alzheimer's disease (1997) Nature, 389, pp. 603-606
Yu, X., Malenka, R.C., Beta-catenin is critical for dendritic morphogenesis (2003) Nat. Neurosci., 6, pp. 1169-1177
Zhang, L., Rubinow, D.R., Xaing, G., Li, B.S., Chang, Y.H., Maric, D., Barker, J.L., Ma, W., Estrogen protects against beta-amyloid-induced neurotoxicity in rat hippocampal neurons by activation of Akt (2001) Neuroreport, 12, pp. 1919-1923
Zhang, H., Zou, K., Tesseur, I., Wyss-Coray, T., Small molecule tgf-beta mimetics as potential neuroprotective factors (2005) Curr. Alzheimer Res., 2, pp. 183-186
Zhu, Y., Culmsee, C., Klumpp, S., Krieglstein, J., Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways (2004) Neuroscience, 123, pp. 897-906
Brazil, D. P., Hemmings, B. A., Ten years of protein kinase B signalling: a hard Akt to follow (2001) Trends Biochem. Sci., 26, pp. 657-66
Brinton, R. D., Impact of estrogen therapy on Alzheimer's disease: a fork in the road? (2004) CNS Drugs, 18, pp. 405-422
Brionne, T. C., Tesseur, I., Masliah, E., Wyss Coray, T., Loss of TGF- 1 leads to increased neuronal cell death and microgliosis in mouse brain (2003) Neuron, 40, pp. 1133-1145
Butterfield, D. A., Reed, T., Newman, S. F., Sultana, R., Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment (2007) Free Radic. Biol. Med., 43, pp. 658-677
Chalmers, K. A., Love, S., Neurofibrillary tangles may interfere with Smad 2/3 signaling in neurons (2007) J. Neuropathol. Exp. Neurol., 66, pp. 158-167
Fuentealba, R. A., Farias, G., Scheu, J., Bronfman, M., Marzolo, M. P., Inestrosa, N. C., Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease (2004) Brain Res. Brain Res. Rev., 47, pp. 275-289
Gaertner, R. F., Wyss-Coray, T., Von Euw, D., Lesne, S., Vivien, D., Lacombe, P., Reduced brain tissue perfusion in TGF-beta 1 transgenic mice showing Alzheimer's disease-like cerebrovascular abnormalities (2005) Neurobiol. Dis., 19, pp. 38-46
Giuffrida, M. L., Grasso, G., Ruvo, M., Pedone, C., Saporito, A., Marasco, D., Pignataro, B., Rizzarelli, E., Abeta (25-35) and its C- and/or N-blocked derivatives: copper driven structural features and neurotoxicity (2007) J. Neurosc. Res., 85, pp. 623-633
Harris-White, M. E., Chu, T., Balverde, Z., Sigel, J. J., Flanders, K. C., Frautschy, S. A., Effects of transforming growth factor-beta (isoforms 1-3) on amyloid-beta deposition, inflammation, and cell targeting in organotypic hippocampal slice cultures (1998) J. Neurosci., 18, pp. 10366-10374
Hock Jr., B. J., Lamb, B. T., Transgenic mouse models of Alzheimer's disease (2001) Trends Genet., 17, pp. S7-S12
Hynd, M. R., Scott, H. L., Dodd, P. R., Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease (2004) Neurochem. Int., 45, pp. 583-595
Inman, G. J., Nicolas, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N. J., Hill, C. S., SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7 (2002) Mol. Pharmacol., 62, pp. 65-74
Kim, E. S., Kim, R. S., Ren, R. F., Hawver, D. B., Flanders, K. C., Transforming growth factor-beta inhibits apoptosis induced by beta-amyloid peptide fragment 25-35 in cultured neuronal cells (1998) Brain Res. Mol. Brain Res., 62, pp. 122-130
Lai, Y. L., Smith, P. M., Lamm, W. J. E., Hildebrandt, J., Sampling and analysis of cerebrospinal fluid for chronic studies in awake rats (1983) J. Appl. Physiol., 54, pp. 1754-1757
Lee, H. G., Ueda, M., Zhu, X., Perry, G., Smith, M. A., Ectopic expression of phospho-Smad2 in Alzheimer's disease: uncoupling of the transforming growth factor-beta pathway? (2006) J. Neurosci. Res., 84, pp. 1856-1861
Luterman, J. D., Haroutunian, V., Yemul, S., Ho, L., Purohit, D., Aisen, P. S., Mohs, R., Pasinetti, G. M., Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia (2000) Arch. Neurol., 57, pp. 1153-1160
Malin, D. H., Crothers, M. K., Lake, J. R., Goyarzu, P., Plotner, R. E., Garcia, S. A., Spell, S. H., Kowall, N. W., Hippocampal injections of amyloid beta-peptide 1-40 impair subsequent one-trial/day reward learning (2001) Neurobiol. Learn. Mem., 76, pp. 125-137
Mattson, M. P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., Rydel, R. E., beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity (1992) J. Neurosci., 12, pp. 376-389
Miguel-Hidalgo, J. J., Cacabelos, R., Beta-amyloid (1-40) -induced neurodegeneration in the rat hippocampal neurons of the CA1 subfield (1998) Acta Neuropathol. (Berl), 95, pp. 455-465
Pike, C. J., Burdick, D., Walencewicz, A. J., Glabe, C. G., Cotman, C. W., Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state (1993) J. Neurosci., 13, pp. 1676-1687
Prehn, J. H., Bindokas, V. P., Jordan, J., Galindo, M. F., Ghadge, G. D., Roos, R. P., Boise, L. H., Miller, R. J., Protective effect of transforming growth factor-beta 1 on beta-amyloid neurotoxicity in rat hippocampal neurons (1996) Mol. Pharmacol., 49, pp. 319-328
Ren, R. F., Flanders, K. C., Transforming growth factors-beta protect primary rat hippocampal neuronal cultures from degeneration induced by beta-amyloid peptide (1996) Brain Res., 732, pp. 16-24
Shapiro, G. I., Preclinical and clinical development of the cyclin-dependent kinase inhibitor flavopiridol (2004) Clin. Cancer Res., 10, pp. 4270-4275
Sortino, M. A., Chisari, M., Merlo, S., Vancheri, C., Caruso, M., Nicoletti, F., Canonico, P. L., Copani, A., Glia mediates the neuroprotective action of estradiol on beta-amyloid-induced neuronal death (2004) Endocrinology, 145, pp. 5080-5086
Swanson, C. J., Bures, M., Johnson, M. P., Linden, A. M., Monn, J. A., Schoepp, D. D., Metabotropic glutamate receptors as novel targets for anxiety and stress disorders (2005) Nat. Rev., Drug Discov., 4, pp. 131-144
TGF-β1 protects against Aβ-neurotoxicity via the phosphatidylinositol-3-kinase pathway
Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L * Combined HAT/EZH2 modulation leads to cancer-selective cell death(284 views) Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2018 May 22; 9(39): 25630-25646. Impact Factor:5.008 ViewExport to BibTeXExport to EndNote